Abstract:Background Left ventricular ejection fraction is the single metric that guides therapeutic decision-making, risk stratification and prognosis in patients with severely impaired systolic function. Although cardiac magnetic resonance imaging (CMR) is the current reference standard for quantification of ventricular volume and function, echocardiography is used more often as it is more widely available and less expensive.(1) Aims To evaluate the correlation between CMR and echocardiography in quantifying left ventricular (LV) volume and function and to determine whether these measurements are associated with clinical outcomes in patients with severe ischemic cardiomyopathy (ICM). Methods Participants recruited to the REVIVED-BCIS2 trial who had undergone baseline CMR or echocardiography were included in this analysis. All scans were analyzed in blinded core laboratories as previously reported.(2,3) All volumes were indexed to body surface area. Spearman correlation, Bland Altman analysis and coverage probability methods were performed to assess the correlation between the two modalities. A Cox proportional hazards model was used to assess the association between imaging metrics and the primary outcome, a composite of all-cause death and aborted sudden death. A sensitivity analysis was conducted a priori, restricted to patients undergoing both scans within 60 days of each other. Results A total of 373 participants with paired imaging data were included: mean age 69±9 years, 87% male, BMI 28±5. A moderate correlation was detected for volume measurements between the modalities (end diastolic volume index (EDVI) r=0.66 end systolic volume index (ESVI) r=0.68), with a weaker correlation for LV ejection fraction (EF) (r=0.41). Bland-Altman plots showed moderate agreement in LVEF measurements (Table 1). The sensitivity analysis included 199 patients, and showed similar results (EDVI r=0.72, ESVI r=0.73 LVEF r=0.43, all p<0.000). Only 7.5% of the paired LVEF measurements were within 5% of each other. 30% of participants were misclassified by echocardiography as having an LVEF>35%. (Figure 1) CMR ESVI was associated with the occurrence of the primary outcome (HR 1.05 per 10ml increment, 95% CI 1.00-1.10) however echo ESVI (HR 1.05 per 10ml increment 95% CI 0.99 – 1.10) and all other imaging metrics were not. Conclusion Left ventricular volumes and ejection fraction on CMR and echocardiography were only modestly correlated in this population with severe ICM. When using the binary EF threshold of 35% that is commonly used to select patients of implantable defibrillator therapy, almost a third of patients at risk would have been missed by echocardiography alone. The additional insights provided by CMR, including scar burden, further support preferential use of this modality in the assessment such patients.

[The role of cardiovascular magnetic resonance imaging in the diagnosis and prognosis of patients with heart failure]

The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction

Cardiovascular magnetic resonance: applications and practical considerations for the general cardiologist

Identification of Fibrosis in Hypertrophic Cardiomyopathy: a Radiomic Study on Cardiac Magnetic Resonance Cine Imaging.

Phenotyping heart failure by cardiac magnetic resonance imaging of cardiac macro- and microscopic structure: state of the art review

CMR to characterise myocardial structure and function in heart failure with preserved left ventricular ejection fraction

The Role of Cardiovascular Magnetic Resonance Imaging in the Assessment of Mitral Regurgitation

Application of cardiac magnetic resonance cine imaging in diagnosis and treatment of heart failure with preserved ejection fraction

Cardiac magnetic resonance in ischemic cardiomyopathy: present role and future directions

The Role of Cardiovascular Magnetic Resonance Imaging in Patients with Cardiac Arrhythmias

Cardiac magnetic resonance in advanced heart failure

Cardiovascular magnetic resonance in the evaluation of heart valve disease

CMR for myocardial characterization in ischemic heart disease: state-of-the-art and future developments

Clinical application of cardiac magnetic resonance imaging in heart failure

Cardiac Magnetic Resonance Imaging in the Evaluation of Functional Impairments in the Right Heart

Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance

Subclinical Myocardial Disease in Heart Failure Detected by CMR

CMR-based cardiac phenotyping in different forms of heart failure

Current Insights and Novel Cardiovascular Magnetic Resonance-Based Techniques in the Prognosis of Non-Ischemic Dilated Cardiomyopathy

Assessment of stable coronary artery disease by cardiovascular magnetic resonance imaging: Current and emerging techniques

The correlation between cardiac magnetic resonance imaging and echocardiography in patients with severe ischaemic cardiomyopathy